中國藥科大學藥學院研究生導師介紹：洪浩

導師信息來源：中國考研網 2016-07-11　相關院校：中國藥科大學

洪浩，博士，教授，博士生導師，教育部創新團隊成員，江蘇省首席科技傳播專家，中國藥理學會神經精神藥理專業委員會委員，中國藥理學會抗衰老與老年癡呆專業委員會委員，江蘇省藥理學會常務理事及教學專業委員會秘書長，“神經藥理學報”編委，“Metabolic Brain Disease”（USA）編委。洪浩教授于1989年6月畢業于中國藥科大學，2001年6月獲安徽中醫學院醫學碩士學位，2004年6月獲中國藥科大學理學博士學位，2006年10月從KinkiUniversity（Japan）留學回國。近年來，承擔藥理學、當代藥理學及表觀遺傳學等課程的教學工作；主持和參加國家自然科學基金面上項目、“十一五”和“十二五”國家“新藥創制”科技重大專項等多項國家及省部級科研項目；在國際知名雜志如Neurobiology of Aging，Int J Neuropsychopharmacol，Neuropharmacology，British J Pharmacol，J Neurochem等發表研究論文30余篇；申請國內發明專利3項；參編著作1部。

研究方向：神經藥理。采用分子遺傳學、細胞分子生物學及動物行為學等實驗方法探尋介導阿爾茨海默病（AD）及相關疾病（如抑郁癥和糖尿病）發生發展的關鍵分子，確證其作為藥物調控的分子靶標，并以此為基礎發掘活性物質、開發防治藥物。當前正在研究的課題有國家自然科學基金面上項目2項、“十二五”國家重大新藥創制項目1項以及江蘇省自然科學基金項目1項。

聯系方式：honghao@cpu.edu.cn;haohongchina@hotmail.com,025-86185227，83271157，江寧校區綜合研發樓551室。

近期已發表的代表性論文:

1. Miao-Jin Ji, Xu-Ben Yu, Zhen-Lin Mei, Yun-Qi An, Su-Su Tang, Mei Hu, Yan Long, Ming-Xing Miao, Qing-Hua Hu, Hong-Bin Sun, Ling-Yi Kong, and Hao Hong*. Hippocampal PPARδ overexpression or activation represses stress-induced depressive behaviors and enhances neurogenesis. Int J Neuropsychopharmacol. In Press.
2. Fang Chen, Rong Rong Dong, Kai Long Zhong, Arijit Ghosh, Su Su Tang, Yan Long, Mei Hu, Ming Xing Miao, Jian Min Liao, Hong Bing Sun, Ling Yi Kong, and Hao Hong*. Antidiabetic drugs restore abnormal transport of amyloid-β across the blood-brain barrier and memory impairment in db/db mice. Neuropharmacology. In Press.
3. Tang SS, Ji MJ, Chen L, Hu M, Long Y, Li YQ, Miao MX, Li JC, Li N, Ji H, Chen XJ, Hong H*. Protective effect of pranlukast on Aβ1-42-induced cognitive deficits associated with downregulation of cysteinyl leukotriene receptor 1. Int J Neuropsychopharmacol. 2014 ;17(4):581-92.
4. Tang SS, Hong H*, Chen L, Mei ZL, Ji MJ, Xiang GQ, Li N, Ji H. Involvement of cysteinyl leukotriene receptor 1 in Aβ1-42-induced neurotoxicity in vitro and in vivo. Neurobiol Aging. 2014;35(3):590-9.
5. Lai J, Hu M, Wang H, Hu M, Long Y, Miao MX, Li JC, Wang XB, Kong LY, Hong H*. Montelukast targeting the cysteinyl leukotriene receptor 1 ameliorates Aβ1-42-induced memory impairment and neuroinflammatory and apoptotic responses in mice. Neuropharmacology. 2014;79:707-14.
6. Wang H, Mei ZL, Zhong KL, Hu M, Long Y, Miao MX, Li N, Yan TH, Hong H*. Pretreatment with antiasthmatic drug ibudilast ameliorates Aβ1-42-induced memory impairment and neurotoxicity in mice. Pharmacol Biochem Behav. 2014；124:373–379.
7. Lai J, Mei ZL, Wang H, Hu M, Long Y, Miao MX, Li N, Hong H*. Montelukast rescues primary neurons against Aβ1-42-induced toxicity through inhibiting CysLT1R-mediated NF-κB signaling. Neurochem Int. 2014 ;75:26-31. (IF:2.659)
8．Du GT, Hu M, Mei ZL, Wang C, Liu GJ, Hu M, Long Y, Miao MX, Chang Li J, Hong H*.
Telmisartan treatment ameliorates memory deficits in streptozotocin-induced diabetic mice via attenuating cerebral amyloidosis. J Pharmacol Sci. 2014;124(4):418-26.
9. Tang SS, Wang XY, Hong H*, Long Y, Li YQ, Xiang GQ, Jiang LY, Zhang HT, Liu LP, Ji H. Leukotriene D4 induces cognitive impairment through enhancement of CysLT₁ R-mediated amyloid-β generation in mice. Neuropharmacology. 2013; 65:182-92. (IF:4.114)
10. Wang XY, Tang SS, Hu M, Long Y, Li YQ, Liao MX, Ji H, Hong H*. Leukotriene D4 induces amyloid-β generation via CysLT(1)R-mediated NF-κB pathways in primary neurons. Neurochem Int. 2013; 62(3):340-7.
11. Liu LP, Yan TH, Jiang LY, Hu W, Hu M, Wang C, Zhang Q, Long Y, Wang JQ, Li YQ, Hu M, Hong H*. Pioglitazone ameliorates memory deficits in streptozotocin-induced diabetic mice by reducing brain β-amyloid through PPARγ activation. Acta Pharmacol Sin. 2013; 34(4):455-63.
12. Xiang GQ, Tang SS, Jiang LY, Hong H*, Li Q, Wang C, Wang XY, Zhang TT, Yin L. PPARγ agonist pioglitazone improves scopolamine-induced memory impairment in mice. J Pharm Pharmacol. 2012; 64(4):589-96.
13. Jiang LY, Tang SS, Wang XY, Liu LP, Long Y, Hu M, Liao MX, Ding QL, Hu W, Li JC, Hong H*. PPARγ agonist pioglitazone reverses memory impairment and biochemical changes in a mouse model of type 2 diabetes mellitus. CNS Neurosci Ther. 2012; 18(8):659-66.